| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Feb 23, 2024 | Option Exercise | $29.06 | 485 | 14,094 | 86,933 | Feb 27, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Feb 22, 2024 | Option Exercise | $27.94 | 246 | 6,873 | 86,168 | Feb 26, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Jan 10, 2024 | Option Exercise | $9.24 | 8,000 | 73,920 | 93,664 | Jan 12, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Jan 10, 2024 | Sale | $27.91 | 8,000 | 223,280 | 85,664 | Jan 12, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 30, 2023 | Option Exercise | $23.99 | 8,100 | 194,319 | 93,349 | Sep 01, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 30, 2023 | Sale | $32.00 | 8,100 | 259,200 | 85,249 | Sep 01, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 25, 2023 | Sale | $31.59 | 5,135 | 162,215 | 85,249 | Aug 29, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Feb 22, 2023 | Option Exercise | $38.57 | 289 | 11,147 | 90,034 | Apr 12, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 22, 2022 | Sale | $35.98 | 5,000 | 179,900 | 87,220 | Aug 23, 2022, 05:16 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 22, 2022 | Option Exercise | $7.90 | 5,000 | 39,500 | 92,220 | Aug 23, 2022, 05:16 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 04, 2022 | Option Exercise | $7.90 | 5,000 | 39,500 | 92,220 | Aug 05, 2022, 04:31 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 04, 2022 | Sale | $32.98 | 5,000 | 164,900 | 87,220 | Aug 05, 2022, 04:31 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Apr 13, 2021 | Sale | $29.98 | 3,125 | 93,702 | 86,326 | Apr 14, 2021, 08:24 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Apr 14, 2021 | Option Exercise | $12.98 | 3,125 | 40,562 | 89,451 | Apr 14, 2021, 08:24 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Apr 14, 2021 | Sale | $31.98 | 3,125 | 99,937 | 86,326 | Apr 14, 2021, 08:24 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Apr 13, 2021 | Option Exercise | $12.98 | 3,125 | 40,562 | 89,451 | Apr 14, 2021, 08:24 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | Martin Tami Tillotson | VP of Regulatory Affairs | Dec 12, 2012 | Option Exercise | $1.83 | 48,125 | 88,200 | 50,625 | Dec 13, 2012, 03:30 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | Martin Tami Tillotson | VP of Regulatory Affairs | May 04, 2012 | Buy | $5.00 | 2,500 | 12,500 | 2,500 | May 07, 2012, 11:41 AM |
Menu